Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[A retrospective study of patients with early onset of multiple sclerosis in Omskaya Oblast.]
[Does interferon beta slow the progression of multiple sclerosis? - Long-term effect of IFN-β on progression of physical disability is still not proven].
Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects.
Acute paraplegia caused by Schistosoma mansoni.
Axon-glia interaction and membrane traffic in myelin formation.
Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient.
Tetrahydrocannabinol for tremor in multiple sclerosis.
Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis.
The MacBlue Binary Transgene (csf1r-gal4VP16/UAS-ECFP) Provides a Novel Marker for Visualisation of Subsets of Monocytes, Macrophages and Dendritic Cells and Responsiveness to CSF1 Administration.
Multifocal Acquired Demyelinating Sensory and Motor Neuropathy: Unexpected Diagnosis After Ultrasound Imaging for a Humeral Fracture.
Cecal Ligation and Puncture Results in Long-Term Central Nervous System Myeloid Inflammation.
CD44 Deficiency Contributes to Enhanced Experimental Autoimmune Encephalomyelitis: A Role in Immune Cells and Vascular Cells of the Blood-Brain Barrier.
Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
The evidence for hypoperfusion as a factor in multiple sclerosis lesion development.
Reliability of Longitudinal Brain Volume Loss Measurements between 2 Sites in Patients with Multiple Sclerosis: Comparison of 7 Quantification Techniques.
Transanal irrigation for bowel symptoms in patients with multiple sclerosis.
Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management.
Breast regression protein-39 is not required for experimental autoimmune encephalomyelitis induction.
Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
Hemolytic anemia following high dose intravenous immunoglobulin in patients with chronic neurological disorders.
4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review.
Costs of multiple sclerosis - extrapolation of Czech data to Polish patients.
Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.
The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation.
Pages
« first
‹ previous
…
390
391
392
393
394
395
396
397
398
…
next ›
last »